Skip to content

Efficacy and safety evaluation test for skin health improvement of lactic acid bacteria fermented unfermented embryo extract (containing GABA)

Efficacy and safety evaluation test for skin health improvement of lactic acid bacteria fermented unfermented embryo extract (containing GABA)

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
CRIS
Registry ID
KCT0007565
Enrollment
120
Registered
2022-07-26
Start date
2021-10-12
Completion date
Unknown
Last updated
2022-09-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Dietary Supplement : Test food: Unfermented embryonic extract capsule (contains 37.5mg per capsule (250mg), once a day, 2 capsules at a time) Control food: Placebo (capsules that do not contain fermen

Sponsors

mariedm
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Korean adults aged 30 to 60 years 2) Those with dry facial skin characteristics as a result of the skin characteristics survey 3) Those with wrinkles around the eyes (visual evaluation grade 3 or higher) 4) A person who has fully explained the purpose and content of the test and voluntarily signed the consent form to participate in the test 5) A healthy person without acute or chronic physical disease including skin disease

Exclusion criteria

Exclusion criteria: 1) Women who are pregnant, lactating, or planning to become pregnant within 6 months 2) Women taking oral contraceptives 3) Those with psychiatric or skin diseases 4) Those with chronic wasting diseases such as asthma, diabetes, high blood pressure, etc. 5) Those with skin abnormalities such as spots, acne, erythema, and capillary dilatation at the test site 6) Those who have used steroid-containing skin exfoliants for more than 1 month for the treatment of skin diseases 7) Those with sensitive, hypersensitive skin 8) Those who have not passed 6 months after participating in the same exam 9) Those who have used the same or similar cosmetics or medicines on the test site within 3 months before the start of the test 10) Those who have received chemical or physical treatment (plastic, dermabrasion, laser, surgery, etc.) on the test site within 6 months before the start of the test 11) Those who are outside the upper limit of each item in the diagnosis of blood test 12) Those who have a specific allergic reaction to food 13) Persons who are executives and employees of this clinical research institute 14) Those who have had a drug-sensitive reaction or allergic reaction 15) Those with cardiovascular disease, endocrine system disease, digestive system disease, urinary system disease 16) Others who are judged to be difficult to perform according to the judgment of the investigator

Design outcomes

Primary

MeasureTime frame
Eye wrinkles evaluation, elasticity evaluation, dermal density evaluation, skin moisture content evaluation, transdermal moisture loss (TEWL) evaluation, skin desquamer evaluation, skin roughness evaluation

Secondary

MeasureTime frame
Adverse reaction ;Clinical pathology test (blood)

Countries

Korea, Republic of

Contacts

Public ContactHoju Jong

mariedm

scaffold@hanmail.net+82-2-2088-3304

Outcome results

None listed

Source: CRIS (via WHO ICTRP) · Data processed: Feb 4, 2026